Application note: Flow cytometry platform
Compendium of iQue® advanced flow cytometry platform application posters: Antibody discovery and immuno-oncology.
List view / Grid view
Compendium of iQue® advanced flow cytometry platform application posters: Antibody discovery and immuno-oncology.
Discover how BioIVT’s portfolio of disease state LEUKOMAX® leukopaks and PBMCs can serve as representative starting materials for autologous cell therapy research.
Learn how R&D Systems™ Avi-tag biotinylated proteins can be used as an alternative to amine biotin coupling in surface plasmon resonance experiments.
Researchers at Synlogic are clearing the path for a new class of medicine – biotherapeutics based on synthetic biology, called synthetic biotics, which are created by programming or engineering bacteria to metabolise or secrete well-validated targets of disease pathophysiology. In this article, Dr Caroline Kurtz, Chief Development Officer at Synlogic, discusses how synthetic…
Discover how BioIVT’s dissociated tumour cells (DTCs) can be used for tumour-infiltrating lymphocyte (TIL) cell therapy research.
Trust in your results — Experience the benefits of iQue® advanced flow cytometry.
This article outlines the advantages of using R&D Systems™ fluorescent-labeled proteins to directly stain and detect CAR+ cells by flow cytometry.
A powerful tool to study complex phenotypes and cellular interactions. Map spatial interactions twice as fast with this second-generation system.
Application note: Quantifying T Cell response in 3D tumour spheroids using advanced flow cytometry workflows.
19 August 2022 | By Sartorius
Want to learn about the latest research and development of cell models in rare diseases? Then watch this virtual panel discussion to hear from industry experts.
This publications review overviews advanced flow cytometry applications in infectious disease and immuno-oncology.
Learn about current and emerging immune checkpoint molecules that are being investigated as potential immuno-oncology targets.
Learn about DLS, a powerful method to characterise the purity and aggregation state of your biologics for improved candidate selection.
R&D Systems offers custom antibody production services to engineer the right antibody to solve your research question with confidence.
This whitepaper overviews how high throughput, multi-parametric analysis accelerates antibody discovery workflows.